Pulmonary Fibrosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pulmonary Fibrosis stocks.

Pulmonary Fibrosis Stocks Recent News

Date Stock Title
Nov 22 OCEA Ocean Biomedical receives notice from Nasdaq regarding late filing
Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
Nov 21 TRVI Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Nov 20 HCWB HCW Biologics prices $6.9M registered direct offering at $1.03 per share
Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
Nov 19 RVPH RVPH: Year-End OLE Update
Nov 19 HCWB HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement
Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
Nov 19 HCWB HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
Nov 18 PLRX Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver MeetingĀ® 2024
Nov 18 HCWB Top Midday Gainers
Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
Nov 18 HCWB Why Is Penny Stock HCW Biologics Surging On Monday?
Nov 18 HCWB HCW Biologics jumps on license agreement for immunotherapeutic product candidate
Nov 18 HCWB HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
Pulmonary Fibrosis

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.Causes include environmental pollution, certain medications, connective tissue diseases, infections (including SARS infections), interstitial lung diseases. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease of unknown cause, is most common. Diagnosis may be based on symptoms, medical imaging, lung biopsy, and lung function tests.There is no cure and there are limited treatment options available. Treatment is directed towards efforts to improve symptoms and may include oxygen therapy and pulmonary rehabilitation. Certain medications may be used to try to slow the worsening of scarring. Lung transplantation may occasionally be an option. At least 5 million people are affected globally. Life expectancy is generally less than five years.

Browse All Tags